GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features-Reference-Cited by-同舟云学术

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Published:2014-05-08 Issue:19 Volume:123 Page:3007-3015
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Wang Tianjiao¹,Feldman Andrew L.²,Wada David A.³,Lu Ye¹,Polk Avery¹,Briski Robert¹,Ristow Kay⁴,Habermann Thomas M.⁴,Thomas Dafydd⁵,Ziesmer Steven C.⁴,Wellik Linda E.⁴,Lanigan Thomas M.⁶,Witzig Thomas E.⁴,Pittelkow Mark R.⁷,Bailey Nathanael G.⁵,Hristov Alexandra C.⁵,Lim Megan S.⁵,Ansell Stephen M.⁴,Wilcox Ryan A.¹

Affiliation:

1. Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI;

2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;

3. Department of Dermatology, University of Utah, Salt Lake City, UT;

4. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN;

5. Department of Pathology, and

6. Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; and

7. Department of Dermatology, Mayo Clinic, Rochester, MN

Abstract

Key Points Alternatively polarized macrophages are abundant constituents of the tumor microenvironment in T-cell lymphoproliferative disorders. GATA-3 expression identifies a subset of PTCL, NOS with a distinct cytokine profile and inferior survival.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/19/3007/1376122/3007.pdf

Reference49 articles.

1. Aggressive lymphomas.;Lenz;N Engl J Med,2010

2. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.;Dave;N Engl J Med,2004

3. Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma.;Steidl;N Engl J Med,2010

4. Cancer-associated myeloproliferation: old association, new therapeutic target.;Wilcox;Mayo Clin Proc,2010

5. Differentiation of effector CD4 T cell populations.;Zhu;Annu Rev Immunol,2010

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State-of-the-Art Updates and Next Questions: Treatment for Newly Diagnosed Peripheral T-Cell Lymphomas;Clinical Lymphoma Myeloma and Leukemia;2024-02

2. Clinicopathological comparison between PTCL‐TBX21 and PTCL‐GATA3 in Japanese patients;Cancer Medicine;2024-01-17

3. Therapeutic challenges in peripheral T-cell lymphoma;Molecular Cancer;2024-01-04

4. Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas;Leukemia Research Reports;2024

5. Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches;The Innovation Medicine;2024